Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A BRKRP
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A EW
Edwards Lifesciences Corporation VEEV
Veeva Systems Inc. A
Agilent Technologies, Inc. TAK
Takeda Pharmaceutical Company Limited RMD
ResMed Inc. IDXX
IDEXX Laboratories, Inc. HLN
Haleon plc CAH
Cardinal Health, Inc. ARGX
argenx SE
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A EW
Edwards Lifesciences Corporation VEEV
Veeva Systems Inc. A
Agilent Technologies, Inc. TAK
Takeda Pharmaceutical Company Limited RMD
ResMed Inc. IDXX
IDEXX Laboratories, Inc. HLN
Haleon plc CAH
Cardinal Health, Inc. ARGX
argenx SE
Performance
| Periode | BRKRP | EW | VEEV | A | TAK | RMD | IDXX | HLN | CAH | ARGX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 27.58 % | 0.08 % | 28.78 % | 39.28 % | -6.79 % | 10.01 % | 46.50 % | -9.14 % | 17.69 % | 32.95 % |
| YTD | 27.58 % | 4.84 % | 39.15 % | 10.94 % | 5.74 % | 13.57 % | 56.74 % | -2.01 % | 37.17 % | 31.79 % |
| 1Y | 27.58 % | 9.69 % | 38.07 % | 13.70 % | 3.24 % | 1.34 % | 41.97 % | -6.09 % | 45.99 % | 46.78 % |
| 3Y | 27.58 % | -11.20 % | 75.80 % | 10.06 % | 9.97 % | 12.83 % | 81.88 % | 49.68 % | 119.60 % | 110.76 % |
| 5Y | 27.58 % | -2.54 % | -1.30 % | 41.48 % | -15.50 % | 43.74 % | 49.40 % | 23.33 % | 237.06 % | 227.69 % |
| 10Y | 27.58 % | 210.78 % | 1 062.32 % | 301.93 % | -41.63 % | 361.40 % | 743.89 % | 23.33 % | 100.33 % | 3 453.57 % |
| From the beginning | 27.58 % | 5 434.55 % | 688.54 % | 413.99 % | -48.78 % | 38 521.48 % | 135 483.72 % | 23.33 % | 17 882.58 % | 3 453.57 % |